Back to Search
Start Over
Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence.
- Source :
-
BMC public health [BMC Public Health] 2022 Jul 08; Vol. 22 (1), pp. 1312. Date of Electronic Publication: 2022 Jul 08. - Publication Year :
- 2022
-
Abstract
- Background: The World Health Organization (WHO) risk assessment algorithm for vertical transmission of HIV (VT) assumes the availability of maternal viral load (VL) result at delivery and early viral control 4 weeks after initiating antiretroviral treatment (ART). However, in many low-and-middle-income countries, VL is often unavailable and mothers' ART adherence may be suboptimal. We evaluate the inclusion of the mothers' self-reported adherence into the established WHO-algorithm to identify infants eligible for enhanced post-natal prophylaxis when mothers' VL result is not available at delivery.<br />Methods: We used data from infants with perinatal HIV infection and their mothers enrolled from May-2018 to May-2020 in Mozambique, South Africa, and Mali. We retrospectively compared the performance of the WHO-algorithm with a modified algorithm which included mothers' adherence as an additional factor. Infants were considered at high risk if born from mothers without a VL result in the 4 weeks before delivery and with adherence <90%.<br />Results: At delivery, 143/184(78%) women with HIV knew their status and were on ART. Only 17(12%) obtained a VL result within 4 weeks before delivery, and 13/17(76%) of them had VL ≥1000 copies/ml. From 126 women on ART without a recent VL result, 99(79%) had been on ART for over 4 weeks. 45/99(45%) women reported suboptimal (< 90%) adherence. A total of 81/184(44%) infants were classified as high risk of VT as per the WHO-algorithm. The modified algorithm including self-adherence disclosure identified 126/184(68%) high risk infants.<br />Conclusions: In the absence of a VL result, mothers' self-reported adherence at delivery increases the number of identified infants eligible to receive enhanced post-natal prophylaxis.<br /> (© 2022. The Author(s).)
- Subjects :
- Algorithms
Anti-Retroviral Agents therapeutic use
Female
Humans
Infant
Infectious Disease Transmission, Vertical prevention & control
Male
Pregnancy
Retrospective Studies
Risk Assessment
Self Report
World Health Organization
Anti-HIV Agents therapeutic use
HIV Infections prevention & control
Pregnancy Complications, Infectious drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1471-2458
- Volume :
- 22
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC public health
- Publication Type :
- Academic Journal
- Accession number :
- 35804333
- Full Text :
- https://doi.org/10.1186/s12889-022-13543-9